Spontaneous Urticaria
📧 Sign up to get email alerts when something new happens for Spontaneous Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) [Phase 2]
BLU-808 is being studied in a Phase 2 trial for Chronic Inducible Urticaria and Chronic Spontaneous Urticaria, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Remibrutinib in Real-world Clinical Practice - a US Sub-study
A US sub-study of real-world clinical practice evaluating remibrutinib for chronic spontaneous urticaria is currently recruiting.
-
CLINICAL_TRIALS other · 2026-02-11Clinical Trial Update: Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. [Phase 3]
A Phase 3 clinical trial update for JYB1904 Injection in adults with chronic spontaneous urticaria; the trial status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China
A completed real-world study in China evaluated the safety and effectiveness of omalizumab (Xolair) for pediatric chronic spontaneous urtica…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria [Phase 1]
Phase 1 study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple-ascending doses of BGB-16673 in adults with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa [Phase 2]
Phase 2 study evaluating safety and pharmacokinetics of INF904 in adults with chronic spontaneous urticaria or hidradenitis suppurativa was …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria [NA]
Completed clinical trial comparing high-dose bilastine (40 mg) to bilastine (20 mg) plus levocetirizine (5 mg) for chronic spontaneous urtic…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) [Phase 1, Phase 2]
This is a dose-escalation study evaluating safety, pharmacokinetics/pharmacodynamics, and preliminary clinical activity of briquilimab in ad…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Analysis of the Role of IgE Proteoforms in Health and Disease
KU Leuven is updating on a clinical trial studying the role of IgE proteoforms in health and disease, with recruitment ongoing across severa…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria
Real-world study evaluating how to intensify omalizumab treatment for chronic spontaneous urticaria.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study of Single Dose of LP-003 in Healthy Adult Subjects [Phase 1]
Phase 1 study evaluating a single dose of LP-003 in healthy adults. The trial status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment [Phase 2]
This Phase 2 trial update reports efficacy and safety data for LP-003 in adults with chronic spontaneous urticaria who remain symptomatic de…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants [Phase 1]
A Phase 1 study evaluating single and multiple doses of LP-003 in healthy adult participants has completed, focusing on safety, tolerability…
-
CLINICAL_TRIALS withdrawal · 2025-12-09Clinical Trial Update: Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria [Phase 2]
A Phase 2 trial of Ritlecitinib (PF-06651600) for chronic spontaneous urticaria has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria [Phase 2]
A Phase 2 multicenter randomized trial of EP262 for chronic spontaneous urticaria was terminated, and the results have been posted.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria
Global managed access program update for remibrutinib in adults with chronic spontaneous urticaria; program is currently available.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes [Phase 1]
Phase 1 study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and the food effect of single and multiple doses of HRS-…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids) [Phase 3]
A Phase 3 pharmacokinetics and safety study of dupilumab in children aged 2 to under 12 with uncontrolled chronic spontaneous urticaria has …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria [Phase 3]
Phase 3 study comparing CMAB007 to Xolair (omalizumab) for chronic spontaneous urticaria is currently recruiting. The trial aims to evaluate…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria [Phase 2]
Phase 2 outpatient trial evaluating ARS-2 for chronic spontaneous urticaria, currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria [Phase 4]
Phase 4 clinical trial updating on extending omalizumab treatment intervals for chronic spontaneous urticaria; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Mepolizumab for the Treatment of Chronic Spontaneous Urticaria [EARLY_Phase 1]
An early Phase 1 trial evaluating mepolizumab for chronic spontaneous urticaria has completed enrollment and posted results in 2025.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001 [Phase 1]
An open-label extension study (AK006-001) for subjects with H1 antihistamine-refractory chronic spontaneous urticaria has completed Phase 1.
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) [Phase 3]
Phase 3 trial LIBERTY-CSU CUPID evaluated dupilumab for chronic spontaneous urticaria in patients who remained symptomatic despite H1 antihi…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
A prospective exploratory biomarker study called SKINERGY sponsored by Leiden University Medical Center is recruiting to profile skin diseas…